fbpx

Boston, MA - June 26 to 28, 2024 | Enrollment Now Open!

Boston, MA - June 26 to 28, 2024
Enrollment Now Open!

20Jul

William G. Kaelin Jr., M.D.

William G. Kaelin Jr., M.D.

2019 Nobel Prize in Physiology or Medicine
Sidney Farber Professor of Medicine, Harvard Medical School

Dr. Kaelin is the Sidney Farber Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, Senior Physician in Medicine at Brigham and Women's Hospital and Howard Hughes Medical Institute Investigator. Dr. Kaelin received the 2019 Nobel Prize in Physiology or Medicine. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the National Academy of Medicine, the American Society of Clinical Investigation, and the American College of Physicians. Dr. Kaelin’s research seeks to understand how, mechanistically, mutations affecting tumor-suppressor genes cause cancer. His laboratory is currently focused on studies of the VHL, RB-1, and p53 tumor suppressor genes. His long-term goal is to lay the foundation for new anticancer therapies based on the biochemical functions of such proteins.

Zack Shinar, M.D.

Zack Shinar, M.D.Board-Certified Emergency Physician, Sharp Memorial HospitalDr. Shinar is…

20Jul

Elizabeth H. Blackburn, Ph.D.

Elizabeth H. Blackburn, Ph.D.

2009 Nobel Prize in Physiology or Medicine
2008 L’Oréal-UNESCO Award for Women in Science
2007 TIME Magazine’s 100 Most influential People

Dr. Blackburn won the Nobel Prize in Physiology or Medicine in 2009 for discovering the molecular nature of telomeres, the ends of chromosomes that serve as protective caps essential for preserving genetic information, and for co-discovering telomerase, an enzyme that maintains telomere ends.

She is the Morris Herztein Professor of Biology and Physiology in the Department of Biochemistry and Biophysics at the University of California, San Francisco (UCSF). Dr. Blackburn and her research team at UCSF work with various cells including human cells, with the goal of continued understanding of telomerase and telomere biology.
Blackburn earned her B.Sc. (1970) and M.Sc. (1972) degrees from the University of Melbourne in Australia, and her Ph.D. (1975) from the University of Cambridge in England. She did her postdoctoral work in Molecular and Cellular Biology from 1975 to 1977 at Yale.

Zack Shinar, M.D.

Zack Shinar, M.D.Board-Certified Emergency Physician, Sharp Memorial HospitalDr. Shinar is…

20Jul

Gregg Semenza, M.D., Ph.D.

2019 Nobel Prize in Physiology or Medicine
2016 Lasker Award for Basic Medical Research

Dr. Semenza is a professor of pediatrics, radiation oncology and molecular radiation sciences, biological chemistry, medicine, and oncology at the Johns Hopkins University School of Medicine. Dr. Semenza is the C. Michael Armstrong Professor of Pediatrics and serves as the director of the vascular program at the Institute for Cell Engineering. Dr. Semenza has led the field in uncovering how cells adapt to changing oxygen levels. He is best known for his groundbreaking discovery of the HIF-1 protein, which controls genes in response to changes in oxygen availability. The finding has far-reaching implications in understanding and treating low-oxygen health conditions such as coronary artery disease and tumor growth. Dr. Semenza was awarded the 2019 Nobel Prize in Physiology or Medicine by the Royal Swedish Academy of Sciences for this groundbreaking research.

Zack Shinar, M.D.

Zack Shinar, M.D.Board-Certified Emergency Physician, Sharp Memorial HospitalDr. Shinar is…

20Jul

Anthony Atala, M.D.

Anthony Atala, M.D.

Director, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
TIME Magazine, Top Medical Breakthroughs and Discoveries

Dr. Atala is a practicing surgeon, researcher, and director of the Wake Forest Institute for Regenerative Medicine. His current work focuses on growing new human cells, tissues, and organs. He is Editor­-in-­Chief of Stem Cells Translational Medicine and Current Stem Cell Research and Therapy. In 2011, he was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Atala’s work has been included twice in Time magazine’s top 10 medical breakthroughs of the year. He was featured in U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century. Over 10 applications of technologies developed in his laboratory have been used clinically. He is the editor of 20 books, has published over 400 journal articles, and has applied for or received over 200 national and international patents.

Linda Clemons

Linda ClemonsBody Language Expert and CEO of Sisterpreneur®Linda Clemons is…

20Jul

Huda Yahya Zoghbi, M.D.

Huda Yahya Zoghbi, M.D.

2020 The Brain Prize
2017 Breakthrough Prize in Life Sciences
2017 Canada Gairdner International Award

Dr. Zoghbi is a professor of pediatrics, molecular and human genetics, neuroscience, and neurology at Baylor College of Medicine and is director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital. Dr. Zoghbi seeks to understand the mechanisms underlying brain development and degeneration.

Working primarily in mouse models and humans, Dr. Zoghbi and her team study the activities of proteins involved in neuropsychiatric disorders such as Rett syndrome, MECP2 duplication syndrome, and mania. They also collaborate with labs studying Drosophila to study the function of proteins that accumulate in late-onset degenerative diseases like Alzheimer’s and inherited movement disorders such as Spinocerebellar ataxia type 1 (SCA1).

The team’s goal is to find ways to reduce abnormal accumulation of proteins in degenerative conditions and normalize protein levels in developmental diseases.

Linda Clemons

Linda ClemonsBody Language Expert and CEO of Sisterpreneur®Linda Clemons is…

20Jul

Michael Rosbash Ph.D.

Michael Rosbash, Ph.D.

2017 Nobel Prize in Physiology or Medicine

The research of Michael Rosbash, Ph.D., focuses on the metabolism and processing of mRNA, the molecular link between DNA and protein, and ultimately led to his receiving the Nobel Prize in Physiology or Medicine in 2017. After arriving at Brandeis University in 1974, Dr. Rosbash began to investigate the genetic influences on circadian rhythms of the internal biological clock within species, particularly fruit flies, that helps them adapt their biological rhythm to the different phases of day and night. In 1984, he and his colleagues identified a gene that encodes a protein that accumulates during the night but is degraded during the day. They also identified additional proteins that form part of a self-regulating biological clockwork in the fruit fly’s cells. The same principles have been shown to apply to other animals and plants.

Linda Clemons

Linda ClemonsBody Language Expert and CEO of Sisterpreneur®Linda Clemons is…

20Jul

George M. Church, Ph.D.

George M. Church, Ph.D.

George M. Church, Ph.D.

Professor of Genetics, Blavatnik Institute, Harvard Medical School
Director, Harvard Medical School National Human Genome Research Institute’s Center of Excellence in Genomic Science
Director, Personal Genome Project, MIT’s Broad Institute and Harvard’s Wyss Institute of Biologically Inspired Engineering

Harvard Professor Dr. Church, is a founding member of the Wyss Institute and director of PersonalGenomes.org, the world’s only open-access information on human genomic, environmental, and trait data.

A pioneer in personal genomics and synthetic biology, he developed the first methods for genome sequencing and dramatic cost reductions (from $3 billion to $600), contributing to nearly all “next-generation sequencing” methods and companies.

His team invented CRISPR for human stem cell genome editing and other synthetic biology technologies and applications, including new ways to create organs for transplantation, gene therapies for aging reversal, and gene drives to eliminate Lyme Disease and Malaria.

Dr. Church is the director of the Intelligence Advanced Research Projects Activity, the National Institutes of Health’s BRAIN Initiative, and the Center for Excellence in Genomic Science. He has co-authored more than 515 papers, 130 patent publications, and one book, Regenesis.

Linda Clemons

Linda ClemonsBody Language Expert and CEO of Sisterpreneur®Linda Clemons is…

20Jul

M Joycelyn Elders

M. Joycelyn Elders, M.D.

Surgeon General of the United States, 1993-1994

Dr. Elders was the first person in the state of Arkansas to become board certified in pediatric endocrinology, the fifteenth Surgeon General of the United States and the first African American, and only the second woman to head the U.S. Public Health Service. Long an outspoken advocate of public health, Dr. Elders was appointed Surgeon General by President Clinton in 1993. In 1996, she wrote her autobiography, Joycelyn Elders, M.D.: From Sharecropper’s Daughter to Surgeon General of the United States of America. Now retired from practice, she is a professor emeritus at the University of Arkansas School of Medicine and remains active in public health education.

Linda Clemons

Linda ClemonsBody Language Expert and CEO of Sisterpreneur®Linda Clemons is…

20Jul

Mario Capecchi

Mario Capecchi, Ph.D.

Science Director, National Academy of Future Physicians and Medical Scientists
Winner, 2007 Nobel Prize in Physiology or Medicine
Winner, 2003 Wolf Prize in Medicine
Winner, 2001 Lasker Award for Basic Medical Research
Recipient, 2001 National Medal of Science

Dr. Capecchi, a biophysicist, is a Distinguished Professor of Human Genetics at the University of Utah School of Medicine. He is best known for his groundbreaking work in gene targeting in mouse embryo-derived stem cells. He was awarded the Nobel Prize in Medicine, along with Martin Evans and Oliver Smithies, for their work in finding ways to manipulate the mammalian genome by inserting new genes into cells. This research led to the breeding of “knock-out mice” and “knock-in mice,” animals with a single gene removed or inserted. His research interests include analysis of early mouse development, neural development in mammals, gene therapy, and production of murine models of human genetic diseases.

Linda Clemons

Linda ClemonsBody Language Expert and CEO of Sisterpreneur®Linda Clemons is…